Phytomedicines Safety and Pharmacovigilance: Some Important Considerations

被引:0
|
作者
Khalid, S. A. [1 ]
机构
[1] Univ Sci & Technol Omdurman, Fac Pharm, Khartoum, Sudan
关键词
D O I
暂无
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
引用
收藏
页码:880 / 880
页数:1
相关论文
共 50 条
  • [1] Why a Bayesian approach to safety analysis in pharmacovigilance is important
    Prieto-Merino, David
    Quartey, George
    Wang, Jixian
    Kim, Joseph
    [J]. PHARMACEUTICAL STATISTICS, 2011, 10 (06) : 554 - 559
  • [2] Clinical PharmacologySpecial Safety Considerations in Drug Development and Pharmacovigilance
    Kwame N. Atuah
    Dyfrig Hughes
    Munir Pirmohamed
    [J]. Drug Safety, 2004, 27 : 535 - 554
  • [3] Some Swazi phytomedicines and their constituents
    Amusan, Oluwole O. G.
    Sukati, Nonhlanhla A.
    Dlamini, Priscilla S.
    Sibandze, Fortunate G.
    [J]. AFRICAN JOURNAL OF BIOTECHNOLOGY, 2007, 6 (03): : 267 - 272
  • [4] Clinical pharmacology - Special safety considerations in drug development and pharmacovigilance
    Atuah, KN
    Hughes, D
    Pirmohamed, M
    [J]. DRUG SAFETY, 2004, 27 (08) : 535 - 554
  • [5] Some important considerations in heatsink design
    Karimpourian, B
    Mahmoudi, J
    [J]. THERMAL, MECHANICAL AND MULTI-PHYSICS SIMULATION AND EXPERIMENTS IN MICRO-ELECTRONICS AND MICRO-SYSTEMS, 2005, : 406 - 413
  • [6] SOME IMPORTANT CONSIDERATIONS IN REACTOR DESIGN
    LUUS, R
    [J]. AICHE JOURNAL, 1972, 18 (02) : 438 - &
  • [7] Some Important Considerations in the Use of Cyclodextrins
    James Blanchard
    Stefan Proniuk
    [J]. Pharmaceutical Research, 1999, 16 : 1796 - 1798
  • [8] Neuroprotection by Estradiol: Some Important Considerations
    Barreto, George E.
    [J]. HUMAN & EXPERIMENTAL TOXICOLOGY, 2011, 30 (10) : 1737 - 1739
  • [9] Some important considerations in the use of cyclodextrins
    Blanchard, J
    Proniuk, S
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (12) : 1796 - 1798
  • [10] Safety implications regarding use of phytomedicines
    Cuzzolin, L
    Zaffani, S
    Benoni, G
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (01) : 37 - 42